See other bills
under the
same topic
PRINTER'S NO. 3641
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
853
Session of
2020
INTRODUCED BY SCHROEDER, HENNESSEY, KIM, BIZZARRO, KORTZ, RYAN,
READSHAW, FREEMAN, LONGIETTI, KINSEY, DONATUCCI, SCHMITT,
SONNEY, STAATS, MALAGARI, BURNS, ROZZI, MILLARD, CIRESI,
M. K. KELLER AND MURT, APRIL 27, 2020
REFERRED TO COMMITTEE ON EDUCATION, APRIL 27, 2020
A RESOLUTION
Designating the week of May 3 through 9, 2020, as "Tardive
Dyskinesia Awareness Week" in Pennsylvania.
WHEREAS, Tardive dyskinesia is a condition of involuntary
muscle movements of the face, trunk and extremities that can
vary in frequency and amplitude; and
WHEREAS, Tardive dyskinesia is a condition that may occur
with certain medications used to treat mental illness, may
result from treatment with dopamine receptor blocking agents
used for both psychiatric and nonpsychiatric conditions and can
persist even after discontinuing those treatments; and
WHEREAS, It is estimated that more than 500,000 Americans
suffer from tardive dyskinesia; and
WHEREAS, According to the National Alliance on Mental
Illness, one in every four patients receiving long-term
treatment with antipsychotic medication will experience tardive
dyskinesia; and
WHEREAS, Anyone taking antipsychotic medication may develop
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
the condition, but people who are elderly, female, diabetic or
have a mental illness are at a greater risk; and
WHEREAS, The House of Representatives believes that it is in
the interest of Pennsylvania to increase public awareness of
tardive dyskinesia, a neurological disorder that is
characterized by repetitive, involuntary muscle movements and
may occur as a side effect of long-term use of antipsychotic and
other medications; therefore be it
RESOLVED, That the House of Representatives designate the
week of May 3 through 9, 2020, as "Tardive Dyskinesia Awareness
Week" in Pennsylvania.
20200HR0853PN3641 - 2 -
1
2
3
4
5
6
7
8
9
10
11